Article
Real-World Outcomes of Patients with Advanced Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer in Canada Using Data Extracted by Large Language Model-Based Artificial Intelligence.
Current oncology (Toronto, Ont.) - 2 Apr 2024
Moulson Ruth, Law Jennifer, Sacher Adrian, Liu Geoffrey, Shepherd Frances A, Bradbury Penelope, Eng Lawson, Iczkovitz Sandra, Abbie Erica, Elia-Pacitti Julia, Ewara Emmanuel M, Mokriak Viktoriia, Weiss Jessica, Pettengell Christopher, Leighl Natasha B
Abstract excerpt
Real-world evidence for patients with advanced EGFR-mutated non-small cell lung cancer (NSCLC) in Canada is limited. This study's objective was to use previously validated DARWENTM artificial intelligence (AI) to extract data from electronic heath records of patients with non-squamous NSCLC at University Health Network (UHN) to describe EGFR mutation prevalence, treatment patterns, and outcomes. Of 2154 patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.